Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Sublinguaal apomorfine effectieve behandeling voor off-periodes bij Parkinson
feb 2020 | Bewegingsstoornissen